{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:55:44Z","timestamp":1794279344696,"version":"4.9.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.leukres.2024.107598","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:36:15Z","timestamp":1727883375000},"page":"107598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Therapeutic advances for the management of adult T cell leukemia: Where do we stand?"],"prefix":"10.1016","volume":"147","author":[{"given":"Hiba","family":"El Hajj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2024.107598_bib1","article-title":"Adult T-cell leukemia and lymphoma in French Guiana: a retrospective analysis with real-life data from 2009 to 2019","volume":"21","author":"Abdelmoumen","year":"2023","journal-title":"Lancet Reg. Health Am."},{"issue":"19","key":"10.1016\/j.leukres.2024.107598_bib2","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jmv.20807","article-title":"Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers","volume":"79","author":"Akimoto","year":"2007","journal-title":"J. Med Virol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009219","article-title":"In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ","volume":"17","author":"Akkouche","year":"2021","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2169\/internalmedicine.9812-22","article-title":"Successful Treatment of an Aggressive Adult T-cell Leukemia\/Lymphoma with Strong CD30 Expression Using Brentuximab Vedotin as Combination and Maintenance Therapy","volume":"62","author":"Baba","year":"2023","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"\"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.\"","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/JVI.01513-06","article-title":"Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells","volume":"81","author":"Banerjee","year":"2007","journal-title":"J. Virol."},{"issue":"44","key":"10.1016\/j.leukres.2024.107598_bib8","doi-asserted-by":"crossref","first-page":"43620","DOI":"10.1074\/jbc.M307275200","article-title":"The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity","volume":"278","author":"Basbous","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib9","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1158\/0008-5472.CAN-03-2390","article-title":"Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism","volume":"64","author":"Bazarbachi","year":"2004","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.leukres.2024.107598_bib10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transpl."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2024.107598_bib13","article-title":"Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients","volume":"13","author":"Bazarbachi","year":"1996","journal-title":"J. Acquir Immune Defic. Syndr. Hum. Retrovirol"},{"issue":"27","key":"10.1016\/j.leukres.2024.107598_bib14","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jnci\/djm269","article-title":"Regulation of telomerase and telomeres: human tumor viruses take control","volume":"100","author":"Bellon","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib17","article-title":"Transcription Independent Stimulation of Telomerase Enzymatic Activity by HTLV-I Tax Through Stimulation of IKK","volume":"8","author":"Bellon","year":"2021","journal-title":"J. Cancer Sci."},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib18","first-page":"1374","article-title":"Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency","volume":"14","author":"Beraud","year":"1994","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2014.09.012","article-title":"Safety, efficacy, and pharmacokinetics\/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia\/lymphoma","volume":"155","author":"Berkowitz","year":"2014","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/jvi.63.4.1578-1586.1989","article-title":"Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins","volume":"63","author":"Bohnlein","year":"1989","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720","article-title":"Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab","volume":"100","author":"Buggins","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107598_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6872-5_1","article-title":"Serological and molecular methods to study epidemiological aspects of human T-cell lymphotropic virus type 1 infection","author":"Cassar","year":"2017","journal-title":"Methods Mol. Biol. 1582"},{"issue":"13","key":"10.1016\/j.leukres.2024.107598_bib23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood.2022016765","article-title":"KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target","volume":"140","author":"Cheminant","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2008-04-149658","article-title":"Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25","volume":"113","author":"Chen","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.2019004045","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"137","author":"Cook","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107598_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fmicb.2012.00406","article-title":"HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways","volume":"3","author":"Currer","year":"2012","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/14656566.2011.571207","article-title":"Newer developments in adult T-cell leukemia\/lymphoma therapeutics","volume":"12","author":"Dasanu","year":"2011","journal-title":"Expert Opin. Pharm."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2014-04-572750","article-title":"ATL response to arsenic\/interferon therapy is triggered by SUMO\/PML\/RNF4-dependent Tax degradation","volume":"125","author":"Dassouki","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1991.423","article-title":"Deoxycoformycin in the treatment of mature T-cell leukaemias","volume":"64","author":"Dearden","year":"1991","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5582\/ddt.2022.01085","article-title":"Valemetostat: first approval as a dual inhibitor of EZH1\/2 to treat adult T-cell leukemia\/lymphoma","volume":"16","author":"Dou","year":"2022","journal-title":"Drug Discov. Ther."},{"issue":"23","key":"10.1016\/j.leukres.2024.107598_bib32","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1016\/S0021-9258(18)41998-9","article-title":"Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B","volume":"267","author":"Duyao","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2024.107598_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957535","article-title":"Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia","volume":"13","author":"El Hajj","year":"2022","journal-title":"Front Immunol."},{"issue":"13","key":"10.1016\/j.leukres.2024.107598_bib34","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","article-title":"Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia","volume":"207","author":"El Hajj","year":"2010","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.leukres.2024.107598_bib35","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.264523","article-title":"Loss of interleukin-10 activates innate immunity to eradicate adult T cell leukemia initiating cells","author":"El Hajj","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3324\/haematol.2020.264523","article-title":"Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells","volume":"106","author":"El Hajj","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107598_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3389\/fmicb.2020.01062","article-title":"Novel Treatments of Adult T Cell Leukemia Lymphoma","volume":"11","author":"El Hajj","year":"2020","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib38","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V99.9.3383","article-title":"Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells","volume":"99","author":"El-Sabban","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib39","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2024.107598_bib40","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.81.19.6207","article-title":"Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia","volume":"81","author":"Franchini","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.leukres.2024.107598_bib41","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation Anti-CCR4 antibody mogamulizumab against adult t-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.leukres.2024.107598_bib42","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood.V97.4.987","article-title":"Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia","volume":"97","author":"Furukawa","year":"2001","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.leukres.2024.107598_bib44","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13149-011-0174-4","article-title":"Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases","volume":"104","author":"Gessain","year":"2011","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.leukres.2024.107598_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological Aspects and World Distribution of HTLV-1 Infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib47","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/jvi.65.3.1628-1633.1991","article-title":"Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis\/HTLV-I-associated myelopathy","volume":"65","author":"Gessain","year":"1991","journal-title":"J. Virol."},{"issue":"26","key":"10.1016\/j.leukres.2024.107598_bib48","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.leukres.2024.107598_bib49","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1086\/420832","article-title":"Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy","volume":"189","author":"Goon","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib50","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.172.3.1735","article-title":"Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I","volume":"172","author":"Goon","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib51","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1074\/jbc.M611031200","article-title":"Activation of NF-kappa B by the human T cell leukemia virus type I Tax oncoprotein is associated with ubiquitin-dependent relocalization of I kappa B kinase","volume":"282","author":"Harhaj","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2010.315","article-title":"LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia\/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway","volume":"25","author":"Hasegawa","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol. J."},{"issue":"26","key":"10.1016\/j.leukres.2024.107598_bib55","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol. J."},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12325-018-0658-4","article-title":"A review of new findings in adult T-cell leukemia-lymphoma: a focus on current and emerging treatment strategies","volume":"35","author":"Hermine","year":"2018","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib58","first-page":"1737","article-title":"Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105","volume":"7","author":"Hirai","year":"1992","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib59","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2024.107598_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11912-021-01138-3","article-title":"Adult T-Cell Leukemia: a comprehensive overview on current and promising treatment modalities","volume":"23","author":"Hleihel","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-023-00841-7","article-title":"Primary cells from patients with adult T cell leukemia\/lymphoma depend on HTLV-1 Tax expression for NF-kappaB activation and survival","volume":"13","author":"Hleihel","year":"2023","journal-title":"Blood Cancer J."},{"issue":"35","key":"10.1016\/j.leukres.2024.107598_bib62","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma","volume":"29","author":"Hodson","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.21918","article-title":"Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): shedding of soluble IL-6R and activation of STAT3 signaling","volume":"119","author":"Horiuchi","year":"2006","journal-title":"Int J. Cancer"},{"issue":"10168","key":"10.1016\/j.leukres.2024.107598_bib64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib65","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bbmt.2019.05.027","article-title":"Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia\/Lymphoma: results of a systematic review\/meta-analysis","volume":"25","author":"Iqbal","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"34","key":"10.1016\/j.leukres.2024.107598_bib66","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia\/Lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib67","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib68","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib69","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMc1807852","article-title":"PD-1 inhibitor therapy in adult T-cell leukemia-lymphoma","volume":"379","author":"Ishitsuka","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib71","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2024.107598_bib72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2022016862","article-title":"An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma","volume":"141","author":"Izutsu","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006861","article-title":"Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection","volume":"14","author":"Kagdi","year":"2018","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12977-019-0484-z","article-title":"Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL","volume":"16","author":"Kannagi","year":"2019","journal-title":"Retrovirology"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/cas.13948","article-title":"Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy","volume":"110","author":"Kannagi","year":"2019","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib76","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet"},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib77","first-page":"696","article-title":"PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma","volume":"379","author":"Kataoka","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"7607","key":"10.1016\/j.leukres.2024.107598_bib78","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.leukres.2024.107598_bib79","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib80","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bbmt.2020.04.006","article-title":"Development of a unique t cell receptor gene-transferred tax-redirected T cell immunotherapy for adult T cell leukemia","volume":"26","author":"Kawamura","year":"2020","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.leukres.2024.107598_bib81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-10-91","article-title":"The combination of arsenic, interferon-alpha, and zidovudine restores an \"immunocompetent-like\" cytokine expression profile in patients with adult T-cell leukemia lymphoma","volume":"10","author":"Kchour","year":"2013","journal-title":"Retrovirology"},{"issue":"26","key":"10.1016\/j.leukres.2024.107598_bib82","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2024.107598_bib83","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.onc.1210804","article-title":"Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome","volume":"27","author":"Kfoury","year":"2008","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2024.107598_bib84","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.cdd.4401624","article-title":"Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway","volume":"12","author":"Kfoury","year":"2005","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2010-05-285742","article-title":"Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome","volume":"117","author":"Kfoury","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107598_bib86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"issue":"18","key":"10.1016\/j.leukres.2024.107598_bib87","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/JVI.76.18.9389-9397.2002","article-title":"5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo","volume":"76","author":"Koiwa","year":"2002","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib88","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.emboj.7601054","article-title":"Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence","volume":"25","author":"Kuo","year":"2006","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib89","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1634\/theoncologist.2017-0524","article-title":"Recent Advances in the Treatment of Peripheral T-Cell Lymphoma","volume":"23","author":"Laribi","year":"2018","journal-title":"Oncologist"},{"issue":"61","key":"10.1016\/j.leukres.2024.107598_bib90","doi-asserted-by":"crossref","first-page":"104664","DOI":"10.18632\/oncotarget.22272","article-title":"Advances in the understanding and management of T-cell prolymphocytic leukemia","volume":"8","author":"Laribi","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib91","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12185-024-03753-9","article-title":"Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis","volume":"119","author":"Lechowicz","year":"2024","journal-title":"Int J. Hematol."},{"issue":"6175","key":"10.1016\/j.leukres.2024.107598_bib92","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/333776a0","article-title":"HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor","volume":"333","author":"Leung","year":"1988","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.leukres.2024.107598_bib93","first-page":"6490","article-title":"A cis element required for induction of the interleukin 2 enhancer by human T-cell leukemia virus type I binds a novel Tax-inducible nuclear protein","volume":"13","author":"Li","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.leukres.2024.107598_bib94","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/bloodadvances.2016001370","article-title":"Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-alpha","volume":"1","author":"Macchi","year":"2017","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib95","doi-asserted-by":"crossref","first-page":"E1269","DOI":"10.1073\/pnas.1715724115","article-title":"Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells","volume":"115","author":"Mahgoub","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.leukres.2024.107598_bib96","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V98.13.3762","article-title":"Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage","volume":"98","author":"Mahieux","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib97","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14712598.2017.1347634","article-title":"Mogamulizumab for the treatment of T-cell lymphoma","volume":"17","author":"Makita","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib98","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12977-020-0513-y","article-title":"Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia\/lymphoma","volume":"17","author":"Marcais","year":"2020","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4049\/jimmunol.1202692","article-title":"Autologous Tax-specific CTL therapy in a primary adult T cell leukemia\/lymphoma cell-bearing NOD\/Shi-scid, IL-2Rgammanull mouse model.\"","volume":"191","author":"Masaki","year":"2013","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib101","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/cas.13654","article-title":"Human T-cell lymphotropic\/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals","volume":"109","author":"Masaki","year":"2018","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib102","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients","volume":"113","author":"Matutes","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9070543","article-title":"Mechanisms of Oncogenesis by HTLV-1 Tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.leukres.2024.107598_bib104","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fmicb.2018.00558","article-title":"Mouse models that enhanced our understanding of adult T cell leukemia","volume":"9","author":"Moodad","year":"2018","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib105","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib106","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/JVI.78.9.4582-4590.2004","article-title":"Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells","volume":"78","author":"Mori","year":"2004","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib107","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood.V84.5.1688.1688","article-title":"Transactivation of the interleukin-1 alpha gene promoter by human T-cell leukemia virus type I tax in T cells","volume":"84","author":"Mori","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jnci\/93.5.367","article-title":"Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo","volume":"93","author":"Mortreux","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib109","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","article-title":"A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients","volume":"103","author":"Moura","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2024.107598_bib110","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2005-09-3572","article-title":"Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation","volume":"107","author":"Nasr","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib111","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib112","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1078-0432.CCR-14-0830","article-title":"Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive\/refractory mycosis fungoides and Sezary syndrome","volume":"21","author":"Ni","year":"2015","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.leukres.2007.05.026","article-title":"\"Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB","volume":"32","author":"Nishioka","year":"2008","journal-title":"Leuk. Res"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib114","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nm0507-527","article-title":"The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells","volume":"13","author":"Ohsugi","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.leukres.2024.107598_bib116","first-page":"21","article-title":"Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy","volume":"11","author":"Oka","year":"2019","journal-title":"Leuk. Res Rep."},{"issue":"21","key":"10.1016\/j.leukres.2024.107598_bib117","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"5838","key":"10.1016\/j.leukres.2024.107598_bib118","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia","volume":"294","author":"Poiesz","year":"1981","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib119","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.V98.4.1200","article-title":"The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors","volume":"98","author":"Portis","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/v3060714","article-title":"Human T-cell lymphotropic virus: a model of NF-\u03baB-associated tumorigenesis","volume":"3","author":"Qu","year":"2011","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib121","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11912-011-0186-8","article-title":"Newly emerging therapies targeting viral-related lymphomas","volume":"13","author":"Ramos","year":"2011","journal-title":"Curr. Oncol. Rep."},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib122","first-page":"696","article-title":"PD-1 inhibitor therapy in adult T-cell leukemia-lymphoma","volume":"379","author":"Ratner","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004420","article-title":"Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma","volume":"4","author":"Ratner","year":"2009","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.leukres.2024.107598_bib124","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1056\/NEJMc1803181","article-title":"Rapid progression of adult T-cell leukemia-lymphoma after PD-1 inhibitor therapy","volume":"378","author":"Ratner","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-16-1022","article-title":"Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia\/lymphoma","volume":"23","author":"Sharma","year":"2017","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib127","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.18281","article-title":"Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma","volume":"198","author":"Shichijo","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib129","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.leukres.2024.107598_bib130","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1128\/JVI.00918-15","article-title":"A transgenic drosophila melanogaster model to study human T-lymphotropic virus oncoprotein tax-1-driven transformation in vivo","volume":"89","author":"Shirinian","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2024.107598_bib131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fmicb.2013.00231","article-title":"Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-\u03baB activation","volume":"4","author":"Shirinian","year":"2013","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib132","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V73.6.1664.1664","article-title":"Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia","volume":"73","author":"Shirono","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107598_bib133","first-page":"1","article-title":"Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies","author":"Siddiqi","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"15","key":"10.1016\/j.leukres.2024.107598_bib134","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.84.15.5389","article-title":"Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I","volume":"84","author":"Siekevitz","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2024.107598_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1375168","article-title":"PCBP1 interacts with the HTLV-1 Tax oncoprotein to potentiate NF-kappaB activation","volume":"15","author":"Su","year":"2024","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107598_bib136","first-page":"670","article-title":"Tax-targeted dendritic cell vaccine therapy for long-term remission of adult T-cell leukemia-lymphoma","volume":"64","author":"Suehiro","year":"2023","journal-title":"Rinsho Ketsueki"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib137","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2024.107598_bib138","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2015-04-641118","article-title":"Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor","volume":"126","author":"Sugata","year":"2015","journal-title":"Blood"},{"issue":"44","key":"10.1016\/j.leukres.2024.107598_bib139","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib140","first-page":"7377","article-title":"Human T-cell leukemia virus type I Tax activation of NF-kappa B\/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene","volume":"14","author":"Sun","year":"1994","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib141","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support","volume":"12","author":"Taguchi","year":"1996","journal-title":"J. Acquir Immune Defic. Syndr. Hum. Retrovirol"},{"issue":"22","key":"10.1016\/j.leukres.2024.107598_bib142","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib143","first-page":"416","article-title":"Surface markers of malignant lymphoid cells in the classification of lymphoproliferative disorders, with special reference to adult T-cell leukemia (author's transl)","volume":"17","author":"Takatsuki","year":"1976","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib144","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib145","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","article-title":"Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia","volume":"88","author":"Tamiya","year":"1996","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib146","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.2910370303","article-title":"Clinical analysis of 33 patients with adult T-cell leukemia (ATL)-diagnostic criteria and significance of high- and low-risk ATL","volume":"37","author":"Tamura","year":"1986","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib147","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hon.3115","article-title":"Lenalidomide treatment for recurrent adult T-cell leukemia\/lymphoma after allogeneic hematopoietic cell transplantation","volume":"41","author":"Tanaka","year":"2023","journal-title":"Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib148","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/imcb.12748","article-title":"Unlocking adult T-cell leukemia\/lymphoma's epigenetic secrets: delving into the mechanism and impact of EZH1\/2 inhibition","volume":"102","author":"Tavakoli Shirazi","year":"2024","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib149","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1349-7006.2010.01833.x","article-title":"Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia.\"","volume":"102","author":"Tian","year":"2011","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib150","first-page":"164","article-title":"Phase I study of YK-176 (2\u2032-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group","volume":"22","author":"Tobinai","year":"1992","journal-title":"Jpn J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11899-012-0124-3","article-title":"Targeting chemokine receptor CCR4 in adult T-cell leukemia-lymphoma and other T-cell lymphomas","volume":"7","author":"Tobinai","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib152","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2024.107598_bib153","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fmicb.2020.01207","article-title":"Diagnostic approaches and established treatments for adult T cell leukemia lymphoma","volume":"11","author":"Tsukasaki","year":"2020","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib154","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02983215","article-title":"Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109)","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int J. Hematol."},{"issue":"34","key":"10.1016\/j.leukres.2024.107598_bib155","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2024.107598_bib156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2016.12.022","article-title":"Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity","volume":"389","author":"Turpin","year":"2017","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib157","first-page":"150","article-title":"Cell surface phenotype and in vitro function of adult T-cell leukemia cells","volume":"1","author":"Uchiyama","year":"1983","journal-title":"Diagn. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib158","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/cas.15431","article-title":"\"Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia\/lymphoma: phase IIb results.\"","volume":"113","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib159","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI111379","volume":"73","author":"Waldmann","year":"1984","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib160","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac","volume":"86","author":"Waldmann","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib161","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2024.107598_bib162","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"issue":"3-4","key":"10.1016\/j.leukres.2024.107598_bib163","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma","volume":"40","author":"White","year":"2001","journal-title":"Leuk. Lymphoma"},{"issue":"29","key":"10.1016\/j.leukres.2024.107598_bib164","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107598_bib165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107598_bib166","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","article-title":"Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas","volume":"29","author":"Yamagishi","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib167","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib168","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V62.4.758.758","article-title":"A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases","volume":"62","author":"Yamaguchi","year":"1983","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib169","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V99.1.88","article-title":"Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP).\"","volume":"99","author":"Yamano","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2024.107598_bib170","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/JVI.00086-10","article-title":"Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 Tax","volume":"85","author":"Yang","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107598_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib172","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/leu.2014.241","article-title":"Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model","volume":"29","author":"Yu","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2024.107598_bib173","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7150\/ijms.30154","article-title":"Histone deacetylases (HDACs) guided novel therapies for T-cell lymphomas","volume":"16","author":"Zhang","year":"2019","journal-title":"Int J. Med Sci."},{"issue":"4","key":"10.1016\/j.leukres.2024.107598_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002025","article-title":"NF-kappaB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ","volume":"7","author":"Zhi","year":"2011","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.leukres.2024.107598_bib175","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.leukres.2011.07.015","article-title":"Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma","volume":"35","author":"Zimmerman","year":"2011","journal-title":"Leuk. Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:16:43Z","timestamp":1732198603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":175,"alternative-id":["S0145212624001644"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107598","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic advances for the management of adult T cell leukemia: Where do we stand?","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107598"}}